Stenting versus Bypass Surgery for the Treatment of Left Main Coronary Artery Disease.
10.3349/ymj.2009.50.6.739
- Author:
Seung Jung PARK
1
Author Information
1. Division of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. sjpark@amc.seoul.kr
- Publication Type:Review ; Research Support, Non-U.S. Gov't
- Keywords:
Bypass surgery;
stents;
coronary disease
- MeSH:
Angioplasty, Transluminal, Percutaneous Coronary/adverse effects/*methods;
Coronary Artery Bypass/*methods;
Coronary Artery Disease/*surgery/*therapy;
Humans;
Stents/adverse effects
- From:Yonsei Medical Journal
2009;50(6):739-743
- CountryRepublic of Korea
- Language:English
-
Abstract:
Based on data comparing coronary-artery bypass grafting (CABG) with medical therapy, the current guidelines recommend CABG as the treatment of choice for patients with left main coronary artery (LMCA) disease. Percutaneous coronary intervention (PCI) can be selectively performed in patients who are candidates for revascularization but who are ineligible for CABG. Current evidence indicates that stenting results in mortality and morbidity rates compared favorably with those seen after CABG. Data from several extensive registries and a large clinical trial may have prompted many interventional cardiologists to choose PCI with stenting as an alternative treatment option for such patients. In addition, these data may inform future guidelines and support the need for well-designed, adequately powered, prospective, randomized trials comparing the two revascularization strategies.
